Category : Search result: pharmaceutical study


Pfizer wins $10B obesity drug takeover battle

Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.

Ontario Studies Highway 401 Tunnel Feasibility

The Ontario government has awarded a crucial contract to study the feasibility of constructing an underground tunnel beneath Highway 401, potentially transforming Toronto's traffic landscape and creating new transportation corridors.

Trump's Plan to Slash Obesity Drug Prices

Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.

$9.1M Study for Doug Ford's Highway 401 Tunnel Plan

The Ontario government is investing $9.1 million in a feasibility study for Premier Doug Ford's visionary plan to build tunnels beneath Highway 401, potentially revolutionizing Toronto-area transportation.

Trump's Drug Price Plan Backfires, Helps Democrats

Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

Daily Steps Could Delay Alzheimer's Progression

Groundbreaking Canadian research shows your daily step count could be a powerful weapon against Alzheimer's disease. Discover how simple walking habits may protect cognitive function.

Top FDA Drug Official Resigns Amid Federal Probe

The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.

Kimberly-Clark Buys Tylenol Maker in $48.7B Deal

In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.

Happiness Boosts Health After Economic Threshold

New Canadian research shows national happiness significantly improves population health, but only when countries pass a crucial economic development threshold. Discover the science behind the happiness-health connection.

Blood Pressure Medication Recall Over Cancer Risk

Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.

Boehringer Ingelheim Licenses Novel Autoimmune Treatment

Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.

Night Light Exposure Linked to Health Risks - Study

Groundbreaking research from Canadian scientists shows that even moderate nighttime light exposure can disrupt sleep patterns and increase cardiovascular risks. Discover how your bedroom environment might be affecting your health.

Hidden Obesity: Why Your BMI Might Be Lying

New Canadian research exposes the limitations of BMI, revealing millions with normal weight may have 'hidden obesity' and face serious health risks. Discover the silent epidemic your scale isn't showing you.

Page 4 of 4